Free Cash Flow Build Up
Relmada Therapeutics, Inc. (RLMD)
$2.94
+0.10 (+3.52%)
Year A/P |
| Revenue |
|---|
| EBITDA |
| EBIT |
| Tax Rate |
| EBIAT |
| Depreciation |
| Accounts Receivable |
| Inventories |
| Accounts Payable |
| Capital Expenditure |
| UFCF |
| WACC |
| PV UFCF |
| SUM PV UFCF |